Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Deloitte
Baxter
Argus Health
US Department of Justice

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 7,638,620

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,638,620
Title:Antisense IAP nucleobase oligomers and uses thereof
Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis and treat proliferative diseases.
Inventor(s): LaCasse; Eric (Ottawa, CA), McManus; Daniel (Ottawa, CA), Durkin; Jonathan P. (Ottawa, CA)
Assignee: Aegera Therapeutics, Inc. (Verdun, Quebec, unknown)
Application Number:11/448,862
Patent Claims:see list of patent claims

Details for Patent 7,638,620

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Aegera Therapeutics, Inc. (Verdun, Quebec, unknown) 2022-03-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Aegera Therapeutics, Inc. (Verdun, Quebec, unknown) 2022-03-27 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Aegera Therapeutics, Inc. (Verdun, Quebec, unknown) 2022-03-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,638,620

Country Patent Number Publication Date
South Africa 200407649 Jul 26, 2006
World Intellectual Property Organization (WIPO) 03080638 May 21, 2004
World Intellectual Property Organization (WIPO) 03080638 Nov 27, 2003
World Intellectual Property Organization (WIPO) 03080638 Oct 02, 2003
United States of America 2003190659 Oct 09, 2003
United States of America 2007032445 Feb 08, 2007
United States of America 2007049544 Mar 01, 2007
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Cipla
Teva
Chubb
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.